FLT3 and acute myeloid leukemia: It has demonstrated effectiveness in improving hematopoietic function and overall survival in relapsed FLT3-ITD AML, restoring hematopoietic function in 12 of 13 patients, and prolonging survival in relapsed/refractory (R/R) cases (7).